Indonesia seeks to launch home-grown Covid-19 vaccine in third quarter


A healthcare worker inoculates a woman with a dose of the Pfizer vaccine against the Covid-19 during a mass vaccination at a shopping mall in Jakarta. Indonesia has aimed to develop and manufacture its own vaccines domestically since the start of the pandemic. - Reuters

JAKARTA, Feb 20 (Jakarta Post/ANN): Indonesia will seek to launch a home-grown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now under way.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Indonesia , Covid-19 , Home Grown , Vaccine , Third Quarter , 2022

Next In Aseanplus News

China baby hospitalised with 600 needle marks after mum stabs him for misbehaviour
Seoul police question Coupang's interim chief for 12 hours over data breach probe
Businesses frustrated that rain still brings Jakarta to a halt
Man randomly attacks four passers-by near Japan station; suspect on the run
Vietnam and US to hold sixth round of reciprocal tariff negotiations
Whale of a time in Preah Sihanouk as large guest drops in
Narita airport allows foreign cargo vehicle drivers without Japan licences
No Nipah virus case detected in Philippines so far: Qurantine Bureau
Toilets at Kota Kinabalu International Airport to get RM11.8mil upgrade
Why China Bulang ethnic group in Yunnan blackens teeth when they reach teenage years

Others Also Read